Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 9.201% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: Cc1nn(Cc2ccccc2Cl)c(C)c1C(=O)OCC(=O)N1CC(C)OC(C)C1
b: COc1cc(NC(=O)Nc2cc(C)on2)cc(OC)c1OC
c: Cc1cc(NC(=O)CCCn2cc([N+](=O)[O-])cn2)n(Cc2ccc(F)cc2)n1
d: COc1ccc(/C=N/NC(N)=S)cc1OC(=O)c1cccc2ccccc12
e: Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccccn3)CC2)cc1
Answer: e. Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccccn3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccccn3)CC2)cc1
Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccccn3)CC2)cc1
[4-(4-methylphenyl)sulfonylpiperazin-1-yl]-pyridin-2-ylmethanone